Zepp Health Corporation (ZEPP)
Zepp Health Statistics
Share Statistics
Zepp Health has 3.63M shares outstanding. The number of shares has increased by -2.83% in one year.
| Shares Outstanding | 3.63M |
| Shares Change (YoY) | -2.83% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 13.03% |
| Shares Floating | 3.6M |
| Failed to Deliver (FTD) Shares | 29.83K |
| FTD / Avg. Volume | 111.75% |
Short Selling Information
The latest short interest is 4.89K, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 4.89K |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.89 and the forward PE ratio is -7.03. Zepp Health's PEG ratio is 0.1.
| PE Ratio | -2.89 |
| Forward PE | -7.03 |
| PS Ratio | 0.25 |
| Forward PS | 0 |
| PB Ratio | 0.25 |
| P/FCF Ratio | 15.14 |
| PEG Ratio | 0.1 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Zepp Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.04 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -1.46 |
| Debt / FCF | 4.85 |
| Interest Coverage | -30.77 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $2.97M |
| Profits Per Employee | $-252.82K |
| Employee Count | 839 |
| Asset Turnover | 3.92 |
| Inventory Turnover | 3.05 |
Taxes
| Income Tax | -2.23M |
| Effective Tax Rate | 6.68% |
Stock Price Statistics
The stock price has increased by -21.21% in the last 52 weeks. The beta is 0.71, so Zepp Health's price volatility has been higher than the market average.
| Beta | 0.71 |
| 52-Week Price Change | -21.21% |
| 50-Day Moving Average | 2.9 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 44.11 |
| Average Volume (20 Days) | 26.7K |
Income Statement
In the last 12 months, Zepp Health had revenue of 2.5B and earned -212.12M in profits. Earnings per share was -3.49.
| Revenue | 2.5B |
| Gross Profit | 657.78M |
| Operating Income | -207.1M |
| Net Income | -212.12M |
| EBITDA | -134.39M |
| EBIT | -26.67M |
| Earnings Per Share (EPS) | -3.49 |
Balance Sheet
The company has 133.88M in cash and 196.08M in debt, giving a net cash position of -62.2M.
| Cash & Cash Equivalents | 133.88M |
| Total Debt | 196.08M |
| Net Cash | -62.2M |
| Retained Earnings | 730.73M |
| Total Assets | 588.79M |
| Working Capital | 47.85M |
Cash Flow
In the last 12 months, operating cash flow was 42.13M and capital expenditures -11.3M, giving a free cash flow of 40.46M.
| Operating Cash Flow | 42.13M |
| Capital Expenditures | -11.3M |
| Free Cash Flow | 40.46M |
| FCF Per Share | 0.67 |
Margins
Gross margin is 26.36%, with operating and profit margins of -8.3% and -8.5%.
| Gross Margin | 26.36% |
| Operating Margin | -8.3% |
| Pretax Margin | -1.34% |
| Profit Margin | -8.5% |
| EBITDA Margin | -5.39% |
| EBIT Margin | -8.3% |
| FCF Margin | 1.62% |
Dividends & Yields
ZEPP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ZEPP.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 16, 2024. It was a backward split with a ratio of 1:4.
| Last Split Date | Sep 16, 2024 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 3 |